Search

everythinglearnresearchcommunity

for

Search:↓

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

A combination of ciclosporin and ketoconazole can effectively treat severe hair loss in dogs.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Naproxen effectively treated a girl's eosinophilic pustular folliculitis when other treatments failed.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Accidentally eating a topical steroid may rarely cause acute generalized pustular psoriasis.

Methotrexate is best for lichen planopilaris, and retinoids are best for frontal fibrosing alopecia, but side effects are common.

A cat's skin condition was fully cured with cyclosporine A after other treatments failed.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Red ink tattoos can cause severe skin reactions and complications, especially in those with autoimmune tendencies.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Early diagnosis and surgery are crucial for managing cryptorchidism and related hair loss in dogs.

Early diagnosis and personalized treatment can lead to significant hair regrowth in children with alopecia areata.

Janus kinase inhibitors are the most supported treatment for pediatric alopecia areata, while other options have limited evidence.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Scalp psoriasis is treated with topical therapies, phototherapy, and systemic medications.